Biotechnology

hylabs is the leading diagnostic company in Israel in the field of microbiology specially in infection diseases. For five decades, it has specialized in the development, production and marketing of services and products for the detection and identification of microorganisms. Today the company leads

Endeavor is a clinical-stage company developing a best-in-class Hedgehog inhibitor for Idiopathic Pulmonary Fibrosis.

RenBio develops antibody-based therapeutic solutions for the treatment of cancer and inflammatory diseases. RenBio's proprietary MYO technology involves in the development of antibody therapeutic that helps in treating rare diseases, viral infections, autoimmune diseases, and more by using DNA bluep

Inimmue is a new biotechnology company founded by pharmaceutical industry veterans focused on developing next-generation immunotherapeutics.

Deterra is the only proven solution that permanently destroys opioids, prescription and over the counter medications. The three-step process is safe, environmentally sound and easy to use. Read on to learn more.

AB-BIOTICS is a Spanish biotech company focused on research, development, protection and distribution of its own biotechnological solutions.

ElevateBio is creating and operating a portfolio of cell and gene therapy companies through partnerships with the world’s most innovative scientists and inventors.

Verge Genomics is a next-generation biopharmaceutical start-up using systems biology to accelerate development of life-saving treatments for neurodegenerative diseases.

Blueprint Medicines Corporation is a biopharmaceutical company. The Company focuses on patients with genomically defined diseases driven by abnormal kinase activation.

At the Pasqual Maragall Foundation we are working towards a future without Alzheimer’s. Our research focuses on how to stop this disease and prevent its progress before the onset of symptoms, given that any damage it causes in the brain begins decades before the disease manifests itself. We also hel

Based in Rockville, Maryland, OncoC4 is a privately-held, clinical-stage biopharmaceutical company that is actively engaged in the discovery and development of novel biologicals for cancer treatment.

Immutep Ltd is a biotechnology company working primarily in the field of cancer immunotherapy.

XOMA has built a significant portfolio of products that are licensed to and being developed by other biotechnology and pharmaceutical companies. The Company’s portfolio of partner-funded programs spans multiple stages of the drug development process and across various therapeutic areas.

BioInvent International AB (Nasdaq Stockholm: BINV) is a clinical-stage biotech company that discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy, with currently three drug candidates in four ongoing clinical programs in Phase l/ll trials for the treatment

Cara Therapeutics is an early commercial-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, or KORs.

Present in Brazil for over 50 years, Apsen is a 100% national pharmaceutical company, which researches, develops and makes excellent medicines available. Apsen operates based on three important pillars: investment in research and development (R&D), investment in the management and development of its

Wugen is a clinical stage immuno-oncology cell therapy company, developing off-the-shelf NK and CAR-T cell therapies for the treatment of both solid tumor and heme malignancies.

Biological Software is one or more synthetic molecules that execute complex functions, specified from a program, in a biological system. We are creating tools to develop increasingly powerful biological software for the rational design of novel, broadly accessible medicines and biotechnologies prev

Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer.

Shattuck is a clinical-stage biotechnology company pioneering the development of bifunctional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease.

Oxitec is a team of passionate individuals from 15 countries improving lives and livelihoods by developing the world's first safe, self-limiting technology to control pests that transmit diseases, destroy crops and harm livestock. Our technology platform allows us to build safe, non-toxic, species

Theravance Biopharma is a biopharmaceutical company with one approved product that was discovered and developed internally, a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies.

Dyne is building a leading muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases.

Personalis is a leader in population sequencing and cancer genomics, with a focus on data, scale, efficiency and quality. Personalis operates one of the largest sequencing operations globally and is currently the sole sequencing provider to the VA Million Veteran Program (MVP). In oncology, Personal

Q32 Bio is a biotechnology company developing therapies targeting powerful regulators of the innate and adaptive immune systems, with the goal of re-balancing the immune system in severe autoimmune and inflammatory diseases.

Vow is crafting a new category of food

Bill & Melinda Gates Medical Research Institute is a biotech organization dedicated to accelerating the product development timeline.

ONL Therapeutics (ONL) is a clinical-stage biopharmaceutical company committed to protecting and improving the vision of patients with a range of retinal diseases and conditions.

Abalone Bio develops antibody drugs that activate, enabling us to turn on previously inaccessible biological activities like anti-cancer or anti-inflammatory actions.

enGenome provides bioinformatics solutions for translational research and clinical routine.

GenomeKey is an award-winning, early-phase company that is exploiting innovative genomic technology.

BioAge is a clinical-stage biotechnology company that develops drugs to treat aging and aging-related diseases.

A2 is dedicated to pushing the boundaries of science to transform medicine and turn the tide on cancer. They are focused on the next frontier in cell therapy: solid tumors.

Erasca is dedicated to advancing exceptional scientific approaches to erase cancer.

Headquartered in Cleveland, Ohio, Codonics develops, designs, sells and supports leading-edge medical imaging and information management devices used in diagnostic imaging. Recognizing a worldwide need for improved medication safety practices, Codonics innovated Safe Label System(SLS) and entered th

Arima Genomics provides unparalleled access to the spatial and temporal changes in the 3D structure of the genome that alters gene regulation and cellular function.

Dianthus Therapeutics is a biotech company developer of therapeutics and drugs.

Founded and headquartered in New York City, Kallyope is developing an industry-leading platform to harness the gut-brain axis.

Achieve Life Science is a privately held specialty pharmaceutical provider.

PureTech (Nasdaq: PRTC, LSE: PRTC) is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastroin

Software to support analysis of MRI for cancer diagnosis, screening and management. Pi(tm), the company's first product, supports diagnosis of prostate cancer using multiparametric or diffusion MRI and is a CE marked medical device. We are interested to speak with investors and hospital partners who

Rani Therapeutics develops bio-therapeutics technology for the oral delivery of large drug molecules.

DF/Net Research offers skilled data management and biostatistical services for biotechnology, pharmaceutical, and private companies.

Lumicell is a biotechnology company that develops and markets image-guided cancer surgery solutions.

Bring Transformational Medicines to Patients Through Innovation

Nimble Therapeutics is using its unique maskless chemical synthesis platform to synthesize and systematically discover novel medicines in a variety of therapeutic areas.

Octant is a well-backed team of experienced scientists and entrepreneurs exploring new frontiers of biology. We are applying next-generation DNA sequencing, gene synthesis, and gene editing to revolutionize drug discovery in a quest for safer, more effective, and cheaper drugs.

CytoKi Pharma is a pre-clinical biotechnology company with focus on serious diseases caused by epithelial injury having an unmet medical need.

Novoheart is a global stem cell biotechnology company that is dedicated to develop and engineer bioartificial human heart prototypes using a combination of world’s first and state-of-the-art stem cell and tissue engineering approaches.

At MTL Labs, they help streamline the business. Driven by customer-centric innovation, their testing solutions provide critical tools to cultivate, manufacture, and distribute cannabis or hemp products.